SYRUPS • SYRUPS

ZYMERIO-B+

Diastase 50mg & Papain Enzymatic 60mg with B-complex Syrup

Schedule H Prescription Drug
Printed MRP: ₹182.41 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
300ml
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
ZYMERIO-B+ Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name ZYMERIO-B+
Active Formulation (Salt) Diastase 50mg & Papain Enzymatic 60mg with B-complex Syrup
Dosage Form SYRUPS
Packaging Presentation 300ml
Therapeutic Category SYRUPS
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is ZYMERIO-B+?

Therapeutic monograph and clinical profile

ZYMERIO-B+ (Diastase 50mg & Papain Enzymatic 60mg with B-complex Syrup) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 300ml, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Indigestion (Dyspepsia) / Bloating and Gas.

Key Formulation Highlights

Why healthcare professionals recommend ZYMERIO-B+

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Indigestion (Dyspepsia) / Bloating and Gas

Pharmacological Mechanism of Action

How ZYMERIO-B+ acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for ZYMERIO-B+

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for ZYMERIO-B+ across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding ZYMERIO-B+

What is ZYMERIO-B+ used for?
ZYMERIO-B+ is prescribed for Indigestion (Dyspepsia) / Bloating and Gas. Always follow physician dosage instructions.
What is the printed packaging and MRP of ZYMERIO-B+?
The printed packaging is 300ml with an MRP of ₹182.41.
How can I get monopoly PCD franchise for ZYMERIO-B+?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.